BMRA实时信号 | 通过Getagraph.com最大化利润

出售 122213 min ago

@ $0.940

发出时间: 10 Feb 2024 @ 03:05

回报率: -40.43%

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	260 910
平均成交量	207 174
市值	9.42M
EPS	$0 ( 2024-04-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.510
ATR14	$0.0140 (2.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Coste Catherine	Buy	75 000	Non-qualified stock option
2023-12-13	Moatazedi David	Buy	75 000	Non-qualified stock option
2023-12-13	Kenny John P.	Buy	75 000	Non-qualified stock option
2023-12-13	Emerson Jane	Buy	75 000	Non-qualified stock option
2023-12-13	Lu Gary	Buy	155 000	Non-qualified stock option

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 712 565 \| Sell: 242 000

音量相关性

長: -0.26 (neutral)

短: -0.63 (weak negative)

Signal:(50.66) Neutral

Biomerica Inc 相关性

10 最正相关
AVGR	0.967
ARVL	0.967
FCBC	0.962
USEG	0.96
ISUN	0.959
ATNF	0.958
CMBM	0.957
SEV	0.957
PMVP	0.957
CAAS	0.956

10 最负相关
MLAI	-0.976
TCMD	-0.974
OXUS	-0.973
TZPS	-0.971
IPAR	-0.969
CBRG	-0.966
BIOT	-0.966
ORIA	-0.964
TZPSU	-0.963
BIOS	-0.962

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Biomerica Inc 相关性 - 货币/商品

0.63
( weak )

0.74
( moderate )

0.00
( neutral )

0.80
( moderate )

0.00
( neutral )

-0.70
( moderate negative )

Biomerica Inc 财务报表

Annual	2023
营收:	$5.34M
毛利润:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2023
营收:	$5.34M
毛利润:	$446 000 (8.35 %)
EPS:	$-0.500

FY	2022
营收:	$18.87M
毛利润:	$2.98M (15.78 %)
EPS:	$-0.360

FY	2021
营收:	$7.20M
毛利润:	$496 981 (6.90 %)
EPS:	$-0.540

Financial Reports:

No articles found.

Biomerica Inc

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.